Clinical Trials on Carcinoid in Russian Federation

Total 533 results

Kidney Cancer Research Bureau

Completed

Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients

Metastatic Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Carcinoma, Renal Cell

Russian Federation
Mona Frolova

Unknown

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Esophageal Neoplasms | Squamous Cell Carcinoma | Concurrent Chemoradiotherapy

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy

Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Unknown

Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.

Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens

Carcinoma, Renal Cell

Russian Federation
Saint Petersburg State University, Russia

Withdrawn

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Poorly Differentiated Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma by AJCC V8 Stage

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (IRIGA)

Gastric Carcinoma Stage IV | Esophagogastric Junction Adenocarcinoma Stage IV

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Esophageal Cancer

Russian Federation
Saint Petersburg State University, Russia

Withdrawn

Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer (ANAPLAST-NEO)

Thyroid Gland Anaplastic Carcinoma

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Completed

Effects of Anesthesia on Immunity in Cancer

Surgery | Renal Cancer

Russian Federation
Bayer

Completed

Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma (SANE)

Carcinoma, Renal Cell

Russian Federation
Biocad

Unknown

A Study of BCD-135 in Patients With Advanced Solid Tumors

Melanoma | Renal Cell Carcinoma | NSCLC | Bladder Cancer

Russian Federation
Autonomous Non-Profit Organization National Society...

Recruiting

Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"

Stage III Non-small Cell Lung Cancer

Russian Federation
N.N. Blokhin National Medical Research Center of...

Recruiting

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy (TRUST)

Non Small Cell Lung Cancer | EGFR Gene Mutation | T790M

Russian Federation
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Russian Federation
Russian Academy of Medical Sciences

Unknown

Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Ovarian Cancer

Russian Federation
Kidney Cancer Research Bureau

Completed

Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

Metastatic Renal Cell Carcinoma

Russian Federation
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

Russian Federation
MelanomaPRO, Russia
Privolzhsky Research Medical University

Recruiting

Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms (CAMELLIA)

Nevus | Nevus, Pigmented | Melanoma (Skin) | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowen's Disease | Nevus, Spitz | Melanoma in Situ | Nevus Halo | Spot Pigmented

Russian Federation
Kidney Cancer Research Bureau

Unknown

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Non-small Cell Lung Cancer Metastatic | Pleural Effusion, Malignant | Renal Cell Cancer Metastatic

Russian Federation
Blokhin's Russian Cancer Research Center

Unknown

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) (EPITOC)

Ovarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous Adenocarcinoma

Russian Federation
Saint Petersburg State University, Russia

Recruiting

Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer

Anaplastic Thyroid Cancer

Russian Federation
Hoffmann-La Roche

Completed

A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer (RuCorT-03)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer (RuCorT-02)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Saint Petersburg State University, Russia

Completed

Normotonic Partial Nephrectomy as Novel Approach in Treating Small Renal Masses (NORPN)

Renal Tumor | Renal Malignant Tumor

Russian Federation
Saint Petersburg State University, Russia

Recruiting

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

Anaplastic Thyroid Cancer

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer (RuCorT-01)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Tomsk National Research Medical Center of the Russian...
Uppsala University; The Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry

Enrolling by invitation

Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Ovarian Cancer | Lung Cancer

Russian Federation
Gene Surgery LLC

Recruiting

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Melanoma | Sarcoma | Uterine Cervical Neoplasms | Breast Neoplasms | Squamous Cell Carcinoma of Head and Neck | Vulvar Neoplasms | Anus Neoplasms | Penile Neoplasms

Russian Federation
Kidney Cancer Research Bureau

Completed

Testosterone in Metastatic Renal Cell Carcinoma Patients (FARETES)

Metastatic Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment

Metastatic Renal Cell Carcinoma

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (RusGCG-01)

Stomach Neoplasms | Gastrointestinal Neoplasms | Docetaxel | Oxaliplatin | Fluoruracil | Irinotecan Hydrochloride

Russian Federation
N.N. Petrov National Medical Research Center of...
Institute of Gene Biology Russian Academy of Sciences

Completed

Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer

Melanoma | Kidney Cancer

Russian Federation
N.N. Petrov National Medical Research Center of...

Recruiting

Clinical Validation of Cervical Cancer Screening Methods

Cervical Cancer | Human Papilloma Virus | Cervical Dysplasia

Russian Federation
Alpha Tau Medical LTD.

Terminated

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.Pathology

Russian Federation
Antisoma Research

Terminated

Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer

Breast Carcinoma

Russian Federation
St. Petersburg State Pavlov Medical University

Recruiting

Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- (GASPACCO)

Gastric Cancer | Peritoneal Carcinomatosis

Russian Federation
Biocad

Active, not recruiting

Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies

Melanoma | Non Small Cell Lung Cancer

Russian Federation
AO GENERIUM

Active, not recruiting

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

Melanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung

Russian Federation
Celgene

Completed

An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin

Non-Small Cell Lung Cancer (NSCLC)

Russian Federation
Eli Lilly and Company

Completed

Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

Carcinoma, Non-Small-Cell Lung

Russian Federation
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Epithelial Ovarian Cancer | Non-small Cell Lung Cancer

Russian Federation
Moscow City Oncology Hospital No. 62

Completed

[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer (SENTRY)

Endometrial Neoplasms | Endometrial Cancer | Sentinel Lymph Node | Endometrial Endometrioid Adenocarcinoma | Endometrial Adenocarcinoma | Hysterectomy | Endometrial Cancer Stage I | Laparoscopic Hysterectomy | Endometrial Cancer Stage II

Russian Federation
Biocad

Unknown

A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors

Melanoma | Renal Cell Carcinoma | Lung Cancer

Russian Federation
State Budget Public Health Institution Scientific...

Active, not recruiting

The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone

Pancreatic Cancer | Bile Duct Cancer | Ampulla of Vater Cancer

Russian Federation
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Ovarian Cancer

Russian Federation
Immanuel Kant Baltic Federal University
Center of Endourology "Endocenter"

Recruiting

Factors Affecting the Results of Treatment of Patients With Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Colon Cancer | Colorectal Adenocarcinoma | Rectal Adenocarcinoma | Colorectal Neoplasms Malignant

Russian Federation

Clinical Trials on Carcinoid in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations